Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

34 results about "Time to hemostasis" patented technology

Hemostasis is a process which takes three to six minutes in normal individuals. Disorders of hemostasis are researched by studying the different time the hemostasis process takes, from the bleeding time, the activated partial thromboplastin time, and the prothrombin time.

Medical hemostatic polysaccharide starch microsphere and preparation method thereof

The invention relates to a preparation method and a refining method of medical hemostatic polysaccharide starch. With pretreated potato starch as a raw material and epichlorohydrin as a crosslinking agent, a microsphere adopting a three-dimensional network structure is synthesized by an emulsifying and crosslinking technology. The medical hemostatic polysaccharide starch is high in biocompatibility; the medical hemostatic polysaccharide starch is full with wrinkles on the surface, so that the particle surface area is increased, the water absorbing rate is significantly improved and the hemostatic time is greatly reduced; the medical hemostatic polysaccharide starch is especially applicable to large-area blood seepage, deep bleeding, and bleeding at a part difficult to reach by operative procedures.
Owner:SHIJIAZHUANG YISHENGTANG MEDICAL SUPPLIES

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site. The method further comprises administering an anticoagulant to a patient at a dose ranging from about 20 units per kg of body weight to about 30 units per kg of body weight.
Owner:VASOINNOVATIONS

Alkyl chitosan-graphene oxide composite sponge and preparation method and application thereof

The invention belongs to the technical field of medical materials, and particularly relates to alkyl chitosan-graphene oxide composite sponge and a preparation method and application thereof. The composite sponge comprises alkyl chitosan and graphene oxide adsorbed on alkyl chitosan, and adsorption capacity of graphene oxide is 3-28%. The composite sponge obtained by taking alkyl chitosan as a matrix and compositing graphene oxide and alkyl chitosan has excellent hemostatic performance and blood absorbing capacity. Embodiment results show that when the composite sponge is used for hemostasis,in-vitro whole blood coagulation time is less than 58s, hemostasis time of a rabbit femoral artery bleeding model is less than 155s, bleeding amount is less than 5.4g, and hemostasis effect is betterthan pure alkyl chitosan sponge or graphene oxide powder.
Owner:INST OF MEDICAL SUPPORT TECH OF ACAD OF SYST ENG OF ACAD OF MILITARY SCI

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site.
Owner:VASOINNOVATIONS

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site. The method further comprises administering an anticoagulant to a patient at a dose ranging from about 20 units per kg of body weight to about 30 units per kg of body weight.
Owner:VASOINNOVATIONS

Hemostatic material based on combination of chitosan and tissue factor, and preparation method thereof

A hemostatic material based on combination of chitosan and a tissue factor, and a preparation method thereof aim to realize short hemostasis time and good hemostasis effects. The hemostatic materialsare mainly prepared from the following components of a formula in parts by mass: 100 parts of the chitosan, 0.1-0.2 milli part of the human recombinant tissue factor, 0.04-0.06 part of phospholipid, 0.1-0.2 part of trehalose and 0.04-0.08 part of CaCl2. The preparation method comprises: preparing an emulsion by high-pressure treatment of the human recombinant tissue factor and the phospholipid, and then preparing a mixture of carboxymethyl chitosan and the human recombinant factor in ways of adding 0.02 ml of the emulsion in each gram of the carboxymethyl chitosan; performing vacuum freezing and drying after pre-freezing of 5-10 h at -40 to -80 DEG C; and grinding and sieving the mixture by a 100-mesh sieve into powder at an environmental temperature of 15-20 DEG C and the humidity of 30%,so as to obtain the external-use quick hemostatic material.
Owner:BEIJING REDCUBE MEDICAL EQUIP +1

Blood vessel ligation device with repeating function

InactiveCN111544076AQuick ligationEffective ligationWound clampsMinimal invasive surgeryExcessive Bleeding
The invention discloses a blood vessel ligation device with a repeating function. The device comprises a gun body, a ligature clamp storage device, an excitation device, a ligature clamp and a fixingclamp, wherein the ligature clamp storage device is arranged on the left side of the gun body; the excitation device is arranged in the gun body; the ligature clamp is stored in the ligature clamp storage device; the ligature clamp is excited by the excitation device; and the fixing clamp is arranged on the gun body. When bleeding is excessive and bleeding points are not easy to find, the goal ofrepeatedly, quickly and effectively ligating blood vessels and tissues can be achieved, hemostasis time is shortened, operative efficiency is improved, success rate of operation is increased, and lifesafety of a patient is maintained. In addition, hemostasis can be achieved quickly in minimally invasive surgery, the intuition of excessive bleeding under the visual angle of an endoscope is avoidedfor surgeons, psychological mood of surgeons is prevented from being affected, and adverse consequences to a surgery are avoided.
Owner:JILIN UNIV FIRST HOSPITAL

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site.
Owner:VASOINNOVATIONS

Method to stop bleeding, with short hemostasis duration using a low dose of anticoagulant

Disclosed are methods and devices for obtaining patent hemostasis of the radial artery by compressing the uninstrumented ulnar artery to increase radial artery flow. The device comprises a band having an inflatable bladder for applying blunt pressure to the ulnar artery. The method comprises applying a pressure to the homolateral ulnar artery and applying a pressure to the radial artery at the access site to obtain hemostasis at the access site. The method further comprises administering an anticoagulant to a patient at a dose ranging from about 20 units per kg of body weight to about 30 units per kg of body weight.
Owner:VASOINNOVATIONS

Uses of cyclic adenosine monophosphate or derivatives thereof in omental hemorrhage after surgical operation

The invention relates to uses of cyclic adenosine monophosphate or derivatives thereof, and specifically relates to uses of cyclic adenosine monophosphate or derivatives thereof in omental hemorrhage after surgical operation. Low dosage of cyclic adenosine monophosphate or derivatives can effectively reduce amount and area of omental hemorrhage after surgical operation, reduce hemostasis time of omental hemorrhage after surgical operation, and relieve the damage degree of human body.
Owner:SHANGHAI JINCHENG PHARMACEUTICAL CO LTD

Inner pile treating orally taken medicine

The present invention discloses one kind of inner pile treating orally taken medicine. The medicine is prepared with date and sulphur as material in certain weight ratio and through unique preparation process based on the different characteristics of the medicine materials. The medicine has the advantages of fast acting, fast hemostasis, fast healing and no recurrence.
Owner:夏志刚

Hemostatic plugging compression device

The invention provides a hemostasis plugging compression device. The hemostasis plugging compression device is used for monitoring the pressure condition between a compression air bag and a shell, thepressure condition between the skin of the patient and a compressor is indirectly reflected, an alarm can be given in time while detecting that the pressure is too large or the compression time is too long, medical staff can come for treatment in time, and great convenience is brought to the patient and the medical staff; the hemostasis time of a tourniquet on the wound surface and the pressure of the tourniquet on the wound surface can be monitored, the tourniquet is automatically inflated or deflated according to an air pressure value in the tourniquet and the hemostasis time to adjust thepressure of the tourniquet on the wound surface so as to improve the hemostasis effect on the wound surface, and therefore the situation that muscle tissue on the wound surface necrotizes due to the fact that the tourniquet continuously presses blood vessels on the wound surface for a long time can be avoided.
Owner:慈溪市人民医院

Method for preparing absorbable haemostatic composition for body and haemostatic composition prepared thereby

The present disclosure relates to a method for preparing an absorbable haemostatic composition for the body and the haemostatic composition prepared thereby, and the present disclosure is for providing a method for preparing an absorbable haemostatic composition for the body and the haemostatic composition prepared thereby, wherein the haemostatic composition can be used directly on the wound site when bleeding occurs in the surgical area such as surgical operation, trauma, etc. so that hemostasis can be effectively performed, the haemostatic composition can perform wound sealing, tissue repairing promotion, wound surface tissue protection, infection prevention, etc., the haemostatic composition is contained in haemostatic products such as gauze (cotton yarn), sponge, etc. to accelerate the hemostasis speed of the bleeding site and enable rapid hemostasis to be able to shorten the hemostasis time at the same time.
Owner:MANTIZ LOGITECH CO LTD

Hemostatic material leading-in device

PendingCN113521516ASelf-rescue is fast and efficientEasy to operateMedical devicesEngineeringTime to hemostasis
The invention discloses a hemostatic material leading-in device. Thehemostatic material leading-in device comprises a barrel transited to a cylinder in a streamline mode, the discharging end of the barrel is composed of a plurality of petal bodies, an inner cavity of the barrel is a hemostatic material containing space, the hemostatic material leading-in device is characterized in that a piston is arranged at the rear end of the barrel, the outer diameter of the piston is consistent with the inner diameter of the barrel, and the piston and the barrel can slide relative to each other in a matched mode; an inner hole is formed in the middle of the piston, a push rod arranged in the cylinder penetrates through the inner hole in the middle of the piston, and the push rod penetrates through the inner hole of the piston and can slide relatively. An elastic piece clamped with the push rod in a matched mode is arranged in an inner hole of the piston. The medicine carrying barrel and the piston push rod are integrally designed, the barrel and the push rod do not need to be assembled during use, only the push rod needs to be pulled out of the barrel, one-hand operation can be achieved, operation is convenient and fast, the hemostasis time is shortened, self rescue of a wounded person is faster and more efficient, and the rescue success rate is effectively increased.
Owner:青岛博益特生物材料股份有限公司

Low-cost antimicrobial and hemostasis ointment and preparation method thereof

The invention discloses a low-cost antimicrobial and hemostasis ointment and a preparation method thereof. The hemostasis ointment is prepared from, by weight 40-60 parts of cafboxymethyl chitosan, 11-18 parts of corn starch, 7-15 parts of aminated dextran, 4-10 parts of potassium alginate, 4-12 parts of earthworm dry powder, 4-9 parts of molecular sieves, 8-16 parts of water-soluble polysaccharide, 14-30 parts of tricalcium phosphate, 8-15 parts of vitamin E acetate, 7-12 parts of lanthanum phosphate, 12-27 parts of glycerinum and 62-90 parts of double distilled water. The hemostasis ointment is short in hemostasis time and small in bleeding amount, the antimicrobial rate is larger than 98.7%, the good hemostasis effect and the good antimicrobial performance in the preliminary stage of a wound are shown, the biological compatibility is good, and the hemostasis ointment is convenient to carry and has the good application prospect.
Owner:王泽陆

Clinical hemostasis rescue equipment for internal medicine department

InactiveCN113499114AEasy to installAdjust squeeze strengthSurgeryTime to hemostasisBiomedical engineering
The invention discloses clinical hemostasis rescue equipment for the internal medicine department. The equipment comprises a main body structure, an extrusion structure and an auxiliary structure, wherein the extrusion structure is detachably arranged on the main body structure, and the auxiliary structure is detachably arranged on the extrusion structure. The invention relates to the technical field of medical instruments. According to the equipment, through cooperation of the main body structure and the extrusion structure, the equipment can be conveniently installed on the limbs of a patient, a rubber band can be pulled by moving a lock frame, the extrusion force can be adjusted, meanwhile, the distance between an extrusion plate and a main body plate can be relatively adjusted, and the equipment can be used according to different thicknesses of the limbs of the patient; the auxiliary structure can be installed to carry out extrusion hemostasis on other wounds. The equipment is convenient and fast to install and convenient to carry, can be adjusted according to the thickness of limbs of a patient, can also adjust the extrusion force to achieve effective hemostasis, and saves hemostasis time.
Owner:滨州市滨城区滨北街道办事处社区卫生服务中心

Micro/nano hierarchical porous microspheres as well as preparation method and application thereof

The invention discloses micro / nano hierarchical porous microspheres as well as a preparation method and application thereof. The preparation method comprises the following steps of (1) preparing a mixed solution of chitin nanofibers and chitosan; (2) preparing a Pickering emulsion; and (3) preparing the micro / nano hierarchical porous microspheres. The preparation method is simple, mild in reactioncondition and low in cost; red blood cells and blood platelets are prevented from entering the microspheres by controlling the pore sizes of the outer surfaces of the prepared microspheres, so that the wound hemostasis time is shortened and wound repair is promoted; the pore walls of the microspheres are connected by chitin nanofibers, so that collagen fiber forms in subcutaneous matrixes in vascular tissues can be simulated; the blood platelets are adhered and activated, so that the acceleration of hemostasis is facilitated, wound surface blood is effectively adsorbed, and the wound surfaceis kept dry; and when the chitosan is in contact with blood, the structure of polycations of the chitosan and the binding force between molecules of the chitosan and cell membranes enable whole bloodto be coagulated, so that the hemostatic process is accelerated, wound infection is inhibited, and cell proliferation is promoted.
Owner:JINAN UNIVERSITY

A kind of preparation method of novel medical hemostatic gel dressing

The invention relates to a method for preparing a medical hemostatic gel dressing. Human-like collagen (LHC) is dissolved in ultrapure water to prepare a protein solution, and inorganic salts and complex cross-linking agents β-diimine zinc complex and 1,2,7,8-Diepoxyoctane, adjust the pH value of the solution to 2-5.5, stir evenly and place the mixed solution in a 40-80°C water bath for 0.5-5h, and then undergo two high-temperature steam treatments in sequence After washing with water, drying and Co-60 irradiation sterilization, a new type of sterile medical hemostatic gel dressing can be obtained. The medical hemostatic gel dressing prepared by the invention has good air permeability and antibacterial properties, will not cause wound infection, and can significantly shorten the hemostasis time. The hemostatic material will not adhere to the wound after hemostasis is completed, which significantly reduces the patient's pain.
Owner:NORTHWEST UNIV

A medical glue with high-efficiency anti-inflammatory and hemostatic functions

The invention discloses a medical adhesive with efficient anti-inflammation and hemostasis functions. The medical adhesive is characterized by comprising, by weight, 20-25 parts of alpha-N-octyl cyanoacrylate, 25-35 parts of alpha-isooctyl cyanoacrylate, 2-6 parts of polyvinyl acetate, 12-20 parts of efficient anti-inflammation components, 13-23 parts of efficient hemostasis components, 3-6 partsof cell activators MG-60, 8-10 parts of allantoin, 1 part of hydrolyzed wheat protein, 1 part of stabilizers, 150-220 parts of compound anti-inflammatory fruit oil components and 200 parts of sterilewater. The medical adhesive particularly selects various extracts with the anti-inflammation and hemostasis functions, two efficient anti-inflammation components and one efficient hemostasis componentare added, so that overall anti-inflammation and hemostasis effects are improved, and the medical adhesive is high in bonding strength and short in hemostasis time and meets application requirementsof clinical medical adhesives.
Owner:浙江派菲特新材料科技有限公司

A kind of absorbable rapid hemostasis material and preparation method thereof

The invention discloses an absorbable rapid bleeding stopping material and a preparation method thereof. The material comprises medicine carrying calcium alginate porous microspheres, oyster shell powder and sodium carboxymethylcellulose. The medicine carrying calcium alginate porous microspheres and the oyster shell powder have the following two functions: firstly, the medicine carrying calcium alginate porous microspheres and the oyster shell powder serve as a molecular sieve, and can rapidly absorb the water in blood when making contact with the blood, so that visible components in the blood can be rapidly concentrated; secondly, the medicine carrying calcium alginate porous microspheres and the oyster shell powder can release a large number of calcium ions for acting on blood coagulation factors which are concentrated on the material surface, blood coagulation is accelerated, bleeding stopping time is shortened, and the amount of bleeding is reduced. The adopted materials are natural macromolecule polysaccharide and inorganic salt, and the characteristics of good biocompatibility, biodegradability, safety, non-toxicity, absorbability, bleeding stopping ability and the like are achieved. The preparation process is simple, the medicine can be released continuously and steadily within a certain period of time, and the absorbable rapid bleeding stopping material can bring great benefits to the medical field and the society.
Owner:JINAN UNIVERSITY

Absorbable hemostatic dressing

The invention discloses an absorbable hemostatic dressing. Comprising the following raw material components in parts by weight: 50-100 parts of hydroxyethyl chitin, 30-80 parts of ossein, 3-10 parts of eel blood extract and 3-10 parts of longflower stringbush root extract. The prepared hemostatic dressing is good in absorbability, wound swelling and infection can be effectively avoided after hemostasis, and few scars are left after healing; the combined use of the eel blood extract and the longflower stringbush root extract prolongs the hemostasis time, and the combined use has a synergistic effect.
Owner:扬州卓和医用材料有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products